Pure Biologics has licensed the patented technology platform PureApta to Novaptech
30 November
2021

Pure Biologics has licensed the patented technology platform PureApta to Novaptech

Pure Biologics has licensed the patented technology platform PureApta™, comprising chemical modifications of aptamers and their applications, to French company Novaptech, who offers tests, sensors and other solutions based on aptamers.
Read more
News
Inquiries
Menu Close

We use cookies to give you the best browsing experience, site traffic analysis, and advertisement management.

Pure Biologics - Harnessing the power of antibodies and aptamers